Skip to content

Maximal and Self-selected Walkingspeed After Knee Arthroplasty - a Prospective Cohort Study

MAXIMAL and SELF-SELECTED WALKING SPEED AFTER KNEE ARTHROPLASTY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06847113
Acronym
LOVKNEE
Enrollment
130
Registered
2025-02-26
Start date
2024-11-20
Completion date
2026-04-30
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroplasty, Total

Brief summary

The purpose of this prospective study is to explore whether maximal and self-selected walking speed in individuals with knee arthroplasty is a useful and applicable clinical measure that can provide new insights into physical function after prosthetic surgery. We will examine the progression of walking speed and other measures of physical function, and investigate if walking speed can predict postoperative function. Individuals over 55 years, scheduled for knee arthroplasty will be invited to participate. Standardized functional tests such as walking speed, sit to stand and one legged stance along with patient reported outcomes will be assessed preoperatively, three months and 12 months after surgery. The study may provide useful knowledge that can be aplied clinically in the assessment and follow-up of this patient group.

Interventions

OTHERPhysical function

Observe walking speed, both maximal and self-selected, over a 12-months period after knee arthroplasty

Sponsors

Lovisenberg Diakonale Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

age 55 +, living in or near the city of Oslo (up to appox 2 hours commute), sceduled for primary knee arthroplasty, able to walk independently with or without walking aids, understand and speak Norwegian sufficently to take instructions and respond to questionnaires

Exclusion criteria

Other reasons than osteoarthritis for knee arthroplasty, revision due to infection or failure, arthroplasty in the same or other limb during the 12 months time period, severe neurological or ohter types of disease that affects walking (e.g MS; parkinsonism, hemiplegiea)

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline to 3 and 12 months in means in maximal and self-selected walking speed walikgnBaseline, 3 months and 12 months after surgeryWalking speed will be measured by 10 meter self-selected and maximal walking speed, respectively. Participant will perform two repetitions of self-selected walking speed, followed by two repetitions of maximal walking speed. Mean, measured by meters per seconds, will be calculated onboth of the two different walking speeds.

Secondary

MeasureTime frameDescription
Sit-to-standBaseline, 3 months and 12 months after surgeryLower extremity strength will be measured by 30 sec sit to stand. Number of standing up in 30 seconds will be counted and recorded
One legged stanceBaseline, 3 months and 12 months after surgeryBalance will be measured by one legged stance. The participant will perform the test by standing on one leg and the other in 90 degrees flexion of the hip and knee, hands on hips. The test will be performed twice, with the non-affected leg to be tested first. The best of the two scores for each leg will be recorded.
Knee specific function and painBaseline and 12 monthsPain and function in the knee will be measured by the patient reported form KOOS which includes 42 questions evaluating pain and function in different activities in daily life the last week.
EQ5D- Health-related quality of lifeBaseline and 12 months after surgeryMeasures self-reported health-related quality of life.

Other

MeasureTime frameDescription
Physical activityBaseline and 12 months after surgeryTo measure physical activity UCLA activity score will be applied. UCLA is a simple scale from 1 to 10 where the participant mark the level that suits their level of activity best. 1 is the lowest, 10 the highest score.

Countries

Norway

Contacts

Primary ContactBrita Stanghelle, PhD
brita.stanghelle@oslomet.no+47 97514751

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026